Abstract-Myocardial stretch triggers an angiotensin II-dependent autocrine/paracrine loop of intracellular signals, leading to reactive oxygen species-mediated activation of redox-sensitive kinases. Based on pharmacological strategies, we previously proposed that mineralocorticoid receptor (MR) is necessary for this stretch-triggered mechanism. Now, we aimed to test the role of MR after stretch by using a molecular approach to avoid secondary effects of pharmacological MR blockers. Small hairpin interference RNA capable of specifically knocking down the MR was incorporated into a lentiviral vector (l-shMR) and injected into the left ventricular wall of Wistar rats. The same vector but expressing a nonsilencing sequence (scramble) was used as control. Lentivirus propagation through the left ventricle was evidenced by confocal microscopy. Myocardial MR expression, stretch-triggered activation of redoxsensitive kinases (ERK1/2-p90 RSK ), the consequent Na + /H + exchanger-mediated changes in pH i (HEPES-buffer), and its mechanical counterpart, the slow force response, were evaluated. Furthermore, reactive oxygen species production in response to a low concentration of angiotensin II (1.0 nmol/L) or an equipotent concentration of epidermal growth factor (0.1 μg/mL) was compared in myocardial tissue slices from both groups. Compared with scramble, animals transduced with l-shMR showed (1) reduced cardiac MR expression, (2) cancellation of angiotensin II-induced reactive oxygen species production but preservation of epidermal growth factor-induced reactive oxygen species production, (3) cancellation of stretch-triggered increase in ERK1/2-p90 RSK phosphorylation, (4) 
W
e recently reported that myocardial stretch induces the activation of the mineralocorticoid receptor (MR). 1 This conclusion was based on the prevention of some of the stretch-triggered consequences by 2 different MR inhibitors, spironolactone and eplerenone. These compounds canceled the stretch-induced activation of redox-sensitive kinases upstream of the Na + /H + exchanger (NHE1), as well as the increase in NHE1 phosphorylation and its mechanical counterpart, the slow force response (SFR). [1] [2] [3] Previous studies demonstrated that inhibiting the NHE1 either pharmacologically or by silencing its expression also prevents these stretch-triggered actions [2] [3] [4] and decreases the production of mitochondrial reactive oxygen species (ROS). 5, 6 However, pharmacological inhibition is not always deprived of nonspecific unwanted effects. Spironolactone is a nonselective compound that also blocks receptors other than the MR. 7 Furthermore, both spironolactone and eplerenone have been described as having an inverse agonist activity on the MR. 8 Therefore, we examined whether conclusive evidence about MR activation after myocardial stretch could be obtained using biomolecular techniques to silence MR expression in rat hearts. For this purpose, we took advantage of the RNA interference technique that we recently used to successfully blunt NHE1 expression in the rat myocardium. 4 Thus, small hairpin interfering RNA directed against the MR was incorporated into a lentiviral vector (l-shMR) and injected into the left ventricular wall of adult Wistar rats. One month later, the effect of stretching papillary muscles on the activation of redox-sensitive kinases, NHE1 activity, and SFR development, as well as the upstream signals mediating the increase in myocardial ROS production, was analyzed. Herein, we provide evidence supporting that myocardial stretch activates the MR, this step being critical for promoting the redoxsensitive kinase-mediated NHE1 stimulation. A preliminary report of our data has been presented elsewhere.
Materials and Methods
All procedures followed during this investigation conform to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (Publication No. 85-23, revised 1996) and to the guidelines laid down by the Animal Welfare Committee of La Plata School of Medicine. Small hairpin interfering RNA capable of mediating specific MR knockdown was incorporated into a lentiviral vector (l-shMR) and injected into the left ventricular wall of Wistar rats. A lentiviral vector expressing a nonsilencing sequence (scramble) was used as control. A complete Materials and Methods section, including the detailed procedure to generate the interference RNA and inject this into the ventricular wall, is detailed in the onlineonly Data Supplement. That section also includes the methodology used to determine myocardial MR mRNA and protein expression, myocardial DsRed fluorescence by confocal microscopy, the stretchtriggered activation of the redox-sensitive kinases ERK1/2 and p90 RSK , the NHE1-mediated changes in pH i , the SFR, and the ROS production.
Results
Lentivirus coding for the small hairpin interfering RNA-MR/ DsRed (l-shMR) or the small hairpin interfering RNAscramble sequence/dsRED (control) was injected into the rat myocardium at 2 sites in the left ventricular free wall near the cardiac apex, and rats were euthanized 1 month later. To check the spreading of the lentivirus, we measured DsRed fluorescence by confocal microscopy in the cardiac tissue from the site of injection to papillary muscles from l-shMR-injected, scramble-injected, and sham-operated (no injections) rats. A patchy red fluorescence distribution was observed in both groups of lentivirus-injected hearts, whereas no signal was detected in the sham-operated group (Figure 1 ). Magnified images highlighting the presence of DsRed inside the myocardial cells in a fascicular-like distribution pattern are shown in Figure S2 in the online-only Data Supplement.
MR protein expression measured in cardiac homogenates of the left ventricular myocardium, as well as in isolated papillary muscles, revealed that hearts injected with l-shMR had an ≈45% reduction in receptor expression compared with the control-injected hearts (P<0.05; Figure 2A and 2B). This result indicates that the small interfering RNA directed against the MR had spread throughout the ventricular myocardium from the sites of injection, as suggested by the confocal images shown in Figure 1 . The injection of l-shMR did not modify the myocardial expression of either GAPDH (control: 100.1±9.8%, n=5; l-shMR: 100±5.3%, n=5) or another steroid receptor such as the glucocorticoid receptor (control: 100.0±7.7%, n=4; l-shMR: 90.9±8.9%, n=4), suggesting that the l-shMR vector specifically targeted the MR, minimizing the possibility of nonspecific effects. Consistent with the reduction in MR protein expression, hearts injected with l-shMR had an ≈55% reduction in MR mRNA abundance compared with those injected with the control vector ( Figure 2C ). Importantly, no changes in MR protein expression were detected either in the lung or in the liver of injected animals ( Figure S3 ), supporting the idea that the presence of l-shMR was restricted to the myocardium. Similar results were obtained when this technique was used to silence the NHE1 by direct injection of a naked interference RNA in the left ventricular wall. 10 Because we have previously shown that the SFR to myocardial stretch is the mechanical counterpart of an autocrine/ paracrine mechanism triggered by the release of endogenous angiotensin II (Ang II) involving MR and NHE1 activation, 11 we decided to functionally test the MR under our experimental conditions by exploring the SFR and NHE1 activation after stretching isolated papillary muscles from l-shMR-and control-injected hearts. The stretching of the papillary muscles in the control group promoted the characteristic biphasic mechanical response, an initial abrupt force increase followed by the SFR (Figure 3A-3C) . On the contrary, the SFR was absent in the papillary muscles isolated from MR-silenced hearts ( Figure 3B and 3C) .
Alkalization of cardiac muscle in bicarbonate-free medium is a key signal of stretch-triggered NHE1 activation 12 ; therefore, we next determined pH i changes after stretching isolated papillary muscles from both experimental groups. As expected, a significant increase in pH i was detected in papillary muscles from control-injected hearts, whereas no pH i changes were observed in the l-shMR-injected group as shown in Figure 4 , revealing the absence of stretch-induced NHE1 activation. The results shown in Figures 3 and 4 indicate that MR activation is crucial to NHE1 stimulation and the SFR development after myocardial stretching, as reported previously based on pharmacological interventions. 1 Myocardial stretch induces NHE1 phosphorylation at Ser703 13 through a mechanism that involves redox-induced activation of ERK1/2 and p90 RSK . 13, 14 As expected, we detected a significant increase in ERK1/2 and p90 RSK phosphorylation after stretching control-injected papillary muscles, an effect that was considerably blunted in muscles from MR-silenced hearts ( Figure 5 ). Therefore, an activated MR is a necessary condition to induce redox-sensitive kinase activation after myocardial stretch.
As we have already mentioned, myocardial stretching induces the activation of the Ang II AT1 receptor, triggering a chain of autocrine/paracrine intracellular signals that through the activation of the epidermal growth factor receptor (EGFR) leads to increased mitochondrial ROS production and activation of redox-sensitive kinases ( Figure 5 ). 13 To further characterize the signals upstream of these kinases, measurement of myocardial O 2˙ production after a low concentration of Ang II (1 nmol/L), which was previously shown to mimic the increase in force observed during the SFR, 15 was compared in tissue slices obtained from control-and l-shMR-injected hearts. Figure 6 shows that Ang II increased O 2˙ production by ≈50% in the control group, whereas this effect was not observed in the myocardial slices from MR-silenced hearts. However, when an equipotent concentration of EGF (0.1 μg/mL) was used to stimulate O 2˙ formation, MR silencing did not abrogate the increase in O 2˙ production observed in the control group ( Figure 6 ), suggesting that the MR is located downstream of the AT1 but upstream of the EGFR in the mitochondrial ROS formation pathway. Taken together, these data unequivocally support that MR activation after myocardial stretch is an important event upstream of myocardial ROS production and ERK1/2, p90 RSK , and NHE1 activation.
Discussion
In the present study, a gene-silencing strategy with small interfering RNA was used to specifically downregulate MR protein expression in the rat myocardium. This approach reduced MR mRNA and protein expression to approximately half in homogenates of the whole left ventricle, as well as in the papillary muscles used for functional studies, an effect that was enough to blunt the stretch-triggered activation of redox-sensitive kinases upstream of the NHE1 and its downstream effects. These results come to extend the relevance of our previous report using eplerenone to prevent MR activation after stretch 1 by providing strong support for the notion that MR activation is a consequence of the intracellular signals triggered by myocardial stretch. The effectiveness of the technique used to silence the myocardial MR seems to be related to the spread of the shMR from cell to cell through connexins, as proposed by Kizana et al. 16 Furthermore, we successfully used this same methodology in a previous work to knockdown the NHE1 expression in rat hearts. 4 In addition, Gupta et al 17 used this technique to silence nuclear factor-κβ, and Schuman et al 18 used this technique to identify the key role of cardiac thyrotropin-releasing hormone in mediating left ventricular hypertrophy in spontaneously hypertensive rats.
The reduction in MR expression at both the protein and mRNA levels found in homogenates of the whole left ventricle of l-shMR-injected hearts was only partial but sufficient to completely prevent the stretch-induced functional effects, proving the effectiveness of the MR-silencing procedure. The modest decrease in MR protein expression that we detected could possibly be a result of insufficient delivery of the lentiviral-transducing units. However, as quoted before, a complete functional inactivation of the receptor was observed. Whether this effect represents a characteristic of MR function, in which 50% of a decrease in the functional units is enough to achieve complete cancellation of the increase in ROS production and its downstream effects, is not apparent to us at this moment.
A link between Ang II or its AT1 receptor and the MR has been reported previously. [19] [20] [21] In connection with this, the release of preformed Ang II by the cardiomyocytes after stretch was proved in elegant experiments by Sadoshima et al 22 and later on by Leri et al. 23 In addition, Browe (within the concentration range reported to be released after myocyte stretching by Sadoshima and Izumo). 22 In the present study, we show that the Ang II-promoted increase in ROS production is also canceled in the MR-silenced myocardium, which is in line with previous reports in smooth and cardiac muscles. 1, 21 However, increased ROS formation in response to EGF was preserved in the myocardium where the MR expression was downregulated. This suggests that in the chain of intracellular signals after myocardial stretch, the role of the MR is upstream of the EGFR and that MR activation is necessary to stimulate the downstream functional effects, confirming our previous findings using either pharmacological inhibition of the MR or a metalloproteinase inhibitor to prevent MR-dependent EGFR transactivation. 1 Furthermore, these results reinforce the notion that EGFR transactivation occurs via the MR 1 and not directly through a G proteincoupled receptor as we proposed previously. 13 The fact that EGFR transactivation can be triggered by MR activation was recognized previously by others. 19, 25, 26 EGFR transactivation seems to be performed by metalloproteinase-dependent cleavage of proheparin-binding EGF, which promotes ectoshedding of heparin-binding EGF. 27, 28 Heparin-binding EGF is a well-known ligand of EGFR, and binding of heparin-binding EGF to EGFR leads to activation of the receptor by tyrosine autophosphorylation. Once EGFR is phosphorylated, the downstream signals increase mitochondrial O 2˙ production. Figure 7 illustrates our hypothesis in which transactivation takes place after metalloproteinase activation subsequent to MR stimulation.
In the present study, we did not explore the mechanism by which myocardial MR becomes activated after stretching.
Aldosterone synthesis by the cardiac myocyte is unlikely in light of previous reports showing that the heart has no or extremely low mRNA of aldosterone synthase and 11-β-hydroxilase. [29] [30] [31] However, myocardial aldosterone was detected in 30% of hearts from adrenalectomized rats, 29 suggesting that the heart is probably able to synthesize small amounts of aldosterone. In any case, aldosterone uptaken by the heart from the circulation, synthesized by the heart, or a combination of both could be released after stretch. It is important to keep in mind that Ang II is the primary stimulus for aldosterone production from the adrenal glands, and pharmacological amounts of exogenous Ang II were reported to increase the aldosterone concentration in the heart and serum. 32 The MR is overexpressed in heart failure, 33, 34 and the clinical efficacy of MR inhibitors in the treatment of heart failure has been well established. [35] [36] [37] However, the exact mechanisms by which MR antagonists provide cardiovascular protection in patients with cardiac failure are not completely understood. From a simplistic point of view, it may be reasoned that elevated circulating levels of aldosterone, resulting in activation of MR in different tissues, could be detrimental; therefore, MR blockade would be beneficial. However, this argument is challenged by the fact that the beneficial effects of MR antagonism are observed even at normal circulating levels of aldosterone 35, [38] [39] [40] and are independent of natriuretic effects. 35, 39, 40 Furthermore, under normal conditions without an increase in oxidative stress, the MR is occupied but not activated by glucocorticoids.
As we reported previously 1 and confirm here in the control-injected hearts (Figure 6 ), MR activation increases ROS formation. Therefore, an expected consequence of Figure 7 . Suggested sequence of events triggered by myocardial stretch. Mineralocorticoid receptor (MR) activation, probably by endogenous formation/release of aldosterone, seems to be located upstream of epidermal growth factor receptor (EGFR) activation in the chain of intracellular signals, leading to the slow force response. Therefore, EGFR transactivation seems to originate from MR and not from G protein-coupled receptor, as we suggested previously. EGFR transactivation seems to result from a metalloproteinase (MMPs)-promoted ectoshedding of heparin-binding EGF (HB-EGF), a known ligand of EGFR, which promotes receptor activation by tyrosine autophosphorylation, leading to mitochondrial reactive oxygen species formation, redox-sensitive kinase activation, and Na the increased oxidative stress should be the enhanced function of the NHE1, as we recently reported. 41 Interestingly, a role for the NHE1 in heart failure was proposed by Baartscheer et al, 42 who in elegant experiments showed that long-term NHE1 inhibition with cariporide decreased the augmented diastolic calcium without significant alteration in systolic calcium in rabbits with hypertrophy and failure. The decrease in diastolic calcium is probably sensed by the prohypertrophic phosphatase, calcineurin, whereas the increase in the calcium transient amplitude increases cardiac inotropism.
Our data suggest that MR antagonism may be followed by inhibition of mitochondrial ROS formation and NHE1 activation, 2 known deleterious signals for the heart. Interestingly, these actions could be responsible, at least in part, for the salutary effects of the MR inhibitors used clinically in heart failure, [35] [36] [37] where an increase in oxidative stress takes place. Our results are in line with previous reports in mice in which ablation of the MR in myocytes preserves cardiac function after chronic pressure overload 43 and also decreases adverse cardiac remodeling after myocardial infarction, 44 2 pathological conditions in which the myocardium is stretched. A similar protection was obtained when mice deprived of myocardial MR were compared with their controls after treatment with deoxycorticosterone acetate/salt. 45 
Perspectives
There is growing evidence showing striking beneficial effects of MR blockade in the treatment of systolic heart failure, a condition in which cardiac muscle is stretched. Despite that these salutary effects have been well documented in 3 different clinical trials (RALES, 35 EPHESUS, 36 and EMPHASIS 37 ), the exact mechanism by which MR inactivation improves heart failure is still not clear. In the present study, by silencing cardiac MR expression, we confirmed its activation after myocardial stretch. MR activation is a step in a chain of events leading to EGFR transactivation, enhanced mitochondrial ROS production, redox-sensitive kinase activation, and NHE1 activation. We can speculate that the decrease in ROS formation after the deactivation of the MR-triggered signaling cascade may be responsible for at least part of the beneficial effects of the clinically used MR blockers in cardiac failure. [35] [36] [37] What Is New?
• We report mineralocorticoid receptor (MR) activation after myocardial stretch.
What Is Relevant?
• Because stretched myocardium is a characteristic of systolic heart failure in which an increase in oxidative stress occurs, silencing of the MR would be beneficial. Our data suggest that MR inhibition is followed by deactivation of mitochondrial reactive oxygen species formation and Na + /H + exchanger stimulation, 2 known deleterious signals of the heart. These actions could be responsible, at least in part, for the salutary effects of the MR inhibitors in patients with heart failure.
Summary
In this study, a gene-silencing strategy was used to specifically downregulate MR protein expression in the myocardium to specifically test the role of MR activation after stretch. Our findings provide strong evidence that MR activation occurs after myocardial stretch and is a key factor promoting redox-sensitive kinase activation and their downstream consequences.
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Materials and Methods
All procedures followed during this investigation conform to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) and to the guidelines laid down by the Animal Welfare Committee of La Plata School of Medicine. Construction and production of lentiviral vectors. A third generation lentiviral vector capable of expressing a reporter gene under the CMV promoter and shRNA under the RNA polymerase III H1 promoter was used as previously described. 1 The shRNA sequence cassette against rat MR (Nr3c2) was constructed inserting in the transfer vector the following sequence: 5'-GCCAACAAGGAAGCCTGAGC -3' (positive strand), followed by: 5'-TTCAAGAGA -3' (loop), 5'-GCTCAGGCTTCCTTGTTGGc -3' (negative strand), and 5' TTTTTT-3' (terminator), at the BamHI cloning site (5' end of the insert ) and PacI cloning site (3' end), downstream of the H1 promoter, to generate PPT.C.DsRed.H1.shMR (l-shMR). This shRNA against MR was proven effective reducing rat kidney MR mRNA and protein expression by Wang et al. 2 Specificity of this sequence was confirmed with the Basic Local Alignment Search, Blast-NCBI; E value < 0.001. For viral vector production, HEK293T cells were plated in T75-cm2 flasks to obtain 80-90 % confluence on the day of transfection, and co-transfected with a four plasmid vector system. The crude viral suspension was harvested from 293T cell cultures 48 and 72 hours after transfection, filtered (0.2 µm), and concentrated using Centricon Plus-70 filter columns (100,000 molecular weight cut-off; Millipore) at 2,000g at 4 °C for 2 hours. 2 Vector aliquots were subsequently stored at -80 °C until use. Vector titers were determined measuring fluorescence of positive HEK293 cells transduced with serial viral dilutions in 293T cells, in the presence of 10 µg/ml of polybrene (Sigma). The same lentiviral vector coding for a disorganized non-silencing nucleotide sequence (scramble) was used as control. Molecular Biology. Plasmids for DNA transfection used here were prepared with Axygen columns. Lentivirus expression vectors have been described previously. 2 Intramyocardial injection of the lentivirus vector. Four to five month old male Wistar rats were anesthetized with sevofluorane (~4 % for induction and 2-3% for maintainance) used in a gas mixture with oxygen and delivered through ventilation by using a positive-pressure respirator (Model 680, Harvard, South Natick, Massachusetts). After reaching deep anesthesia, a left thoracotomy was performed via the fourth intercostal space, the lungs retracted to expose the heart. Following this, the l-shMR or the scramble lentivirus (~2×10 7 transducing units in 200 µl volume, multiplicity of infection (MOI~80)) were intramyocardially injected at two sites in the free wall of the left ventricle, close to the cardiac apex, using a 30G needle 3 ( Figure S1 ). After injection, the lungs were inflated by increasing positive end-expiratory pressure, and the thoracotomy site was closed in layers. Immediately after surgery, rats were returned to their cages and carried to a recovery room and subsequently returned to the animal facility until sacrifice (1 month later). Rats had ad libitum access to food and water. Myocardial DsRed fluorescence. Confocal images: Samples were kept in buffered formalin during 24 hs. and then serially cut into 10-µm thick sections using a vibratome (Leica VT 1000S). Mounted slices were incubated for 15 min with the fluorescent DNA stain DAPI. Fluorescence was detected using a confocal microscope (Olympus FV1000). Solid state lasers 2 559 and 405 were used for excitation of DsRed and DAPI fluorophores, respectively. A 10x objective was used for determining viral distribution in the tissue. A 40x (UPlanSAPO, NA 0.95) objective with 5x zoom factor of the microscope was used for registering cellular details. For capturing the images, the intensity of the laser 559 and of its photomultiplier were kept constant to qualitatively compare the samples. Western blots. Tissue samples were prepared from freshly isolated lung, liver, and left ventricle one month after lentiviral injection. Briefly, the samples were washed with PBS buffer and homogenized in lysis buffer: 300 mmol l −1 sacarose; 1 mmol l −1 DTT; 4 mmol l
EGTA, protease inhibitors cocktail (Complete Mini Roche); 20 mmol l −1 Tris-HCl, pH 7.4. After a brief centrifugation the supernatant was kept and protein concentration determined by the Bradford method. Samples were denatured and equal amounts of protein subjected to PAGE and electrotransferred to PVDF membranes. After blocking with non-fat dry milk membranes were incubated with the corresponding primary antibodies: monoclonal mouse anti-MR (kind gift of Dr. Gomez-Sanchez); polyclonal anti P-p90 RSK ; polyclonal anti P-ERK1/2 (Santa Cruz Biotechnology); and monoclonal mouse anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Santa Cruz Biotechnology). Peroxidase conjugated anti rabbit or anti mouse (Santa Cruz Biotechnology) were used as secondary antibodies. Bands were visualized with enhanced chemiluminescence reagent (ECL, Millipore) and a Chemidoc Station (Bio-Rad), and quantified using Image analysis software. Results were expressed normalized by the corresponding GAPDH signal. Determination of MR mRNA content by quantitative real-time PCR. Total RNA was extracted from frozen ventricular samples using the Qiagen RNeasy Mini kit. RNA (0.8 g) was reversetranscribed using the Omniscript RT kit (Qiagen). A dilution of the resulting cDNA was used to quantify the relative content of mRNA by real-time PCR (iCycler iQ real-time PCR detection system, Bio-Rad) using specific primers and SYBR Green as the fluorescent probe. The following primers were used: forward 5-GCGAAACAGATGATCCAGGT-3 and reverse 5-CAACTCAAAGCGAACGATGA-3. PCR was performed with Taq DNA polymerase (Invitrogen). Fluorescence data were acquired at the end of the extension step. A melt analysis was run for all products to determine the specificity of the amplification. The cycle threshold values for each gene were measured and calculated by computer software (iCycler IQ OSS, version 3.0a, Bio-Rad). Determination of SFR and pH i changes after myocardial stretch in isolated papillary muscles. Isolated papillary muscles were used to assess the SFR and the pH i changes after stretch as previously done. 4 Briefly, the muscles were mounted in a perfusion chamber placed on the stage of an inverted microscope (Olympus) and bathed with a CO 2 /HCO 3 --buffered solution containing (mmol/L) NaCl 128.3, KCl 4.5, CaCl2 1.35, NaHCO3 20.23, MgSO4 1.05, glucose 11.0 and equilibrated with 5% CO2/95% O2 (pH ~7.40). The possible participation of cathecholamines released by the nerve endings was prevented by adrenergic receptors blockade with 1.0 µmol/L prazosin plus 1.0 µmol/L atenolol. The muscles were paced at 0.2 Hz at a voltage 10% over threshold, maintained at 30°C, and isometric contractions were recorded. Cross sectional area (calculated as 0.75 of the product of thickness by width) was used to normalize force records obtained with a silicon strain gauge (model AEM 801, SensoNor). Two papillary muscles per rat were dissected. The slack length of each muscle was determined after mounting, and subsequently they were progressively stretched to the length at which they developed maximal twitch force (Lmax). Then, the muscles were shortened to 92 % of the length at which they exerted maximal developed force (L92) and maintained at this length until the beginning of the experimental protocol, when they were abruptly stretched to L98 (98 % of the length at which they exerted maximal developed force).
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The BCECF-epifluorescence technique described elsewhere was used to measure pH i . 4 The experiments were performed in the nominal absence of bicarbonate (HEPES buffer) to assure that the only operative pH i regulatory mechanism was the NHE1. Measurement of superoxide anion (O 2˙) production: Cardiac slices from the left ventricle (1x 5mm) were dissected and kept at 4 °C until assayed. We used the lucigenin-enhaced chemiluminescence to measure O 2˙ production by rat cardiac tissue in Krebs-Hepes buffer with 5 µM lucigenin as previously described. 5 Briefly, cardiac slices were incubated in assay buffer in the absence or presence of angiotensin II (Ang II), during 30 min in a metabolic incubator under 95% O 2 -5% CO 2 at 37°C before measuring O 2˙. Chemiluminescence in arbitrary units was recorded with a luminometer (Chameleon; Hidex; Finland) during 30 sec. each with 4.5 min interval during 30 min. The lucigenin-containing assay buffer with tissue slices minus background and the responses to the drug assayed were reported. O 2˙ production was normalized to milligrams dry weight tissue per minute. Statistics. Data are expressed as mean ± SEM. Student "t" test or one-way ANOVA followed by Student-Newman-Keuls test when appropriate were used to compare data. Two-way ANOVA was used to compare post-stretch force and pH i data in scramble and l-shNHE1-injected papillary muscles. A p value < 0.05 was considered of statistical significance. Figure S1 . Schematic representation of a heart indicating the sites of injection of the lentiviral vectors and the myocardial samples used for each experiment. The l-shMR or the scramble lentivirus were intramyocardially injected at two sites in the free wall of the left ventricle, close to cardiac apex by a 30G needle ("a"). Papillary muscles were used for functional experiments and kinase activation (ERK1/2-p90 RSK ) determinations ("b"). Myocardial tissue slices from the left ventricle were used for superoxide anion determinations ("c"). Whole left ventricular homogenates were used for MR protein expression as well as for mRNA content determinations ("d"). 
